NCT02474524

Brief Summary

This project is a component of a broader research program referred to as "Self-Management and Recovery Technology (SMART): Use of online technology to promote self-management and recovery in people with psychosis", which has been funded by the Victorian Department of Health Mental Illness Research Fund (MIRF33). The overall research program is examining the therapeutic potential of using online (Internet-based) educational and multimedia resources in mental health services. It involves the development of a website which can be accessed via an internet browser on a desktop computer, tablet computer, or smartphone. It consists of a series of educational modules containing textual information, exercises, audio, and video clips designed to promote self-management and recovery in people with a history of persisting mental illness. This particular project (SMART-Therapy) involves a randomised controlled trial examining the use of a discrete 8-session psychosocial intervention delivered in addition to routine care which utilises these online materials. The intervention will involve a mental health worker meeting with the participant with a tablet computer (e.g. iPad) on which online materials can be viewed, and used to guide an interaction with the participant. The randomised controlled trial will include 148 participants, who will be randomised to receive one of two interventions: (a) meeting with a support worker using the SMART website to guide interaction (health intervention), or (b) meeting with a support worker delivering a social interaction-based control condition (social intervention). In each condition, there will be 8 x 50min face-to-face sessions over 3 months. Assessments will be completed pre-randomisation, and at 3, 6 and 9 months. The primary hypothesis is that participants randomised to the health intervention will show greater improvement in personal recovery than participants randomised to the social intervention, and that these improvements will be maintained at follow-up (6 and 9 months following intake).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable schizophrenia

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2015

Completed
24 days until next milestone

First Posted

Study publicly available on registry

June 17, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

September 15, 2017

Status Verified

September 1, 2017

Enrollment Period

2.4 years

First QC Date

May 24, 2015

Last Update Submit

September 14, 2017

Conditions

Keywords

PsychosisSchizophreniaSelf-managementRecoveryTablet computerDigital healthInternetOnlinePeer support

Outcome Measures

Primary Outcomes (1)

  • Change in Process of Recovery Questionnaire (QPR)

    Assesses personal recovery

    Baseline, 3, 6 and 9 months

Secondary Outcomes (5)

  • Change in Positive and Negative Syndrome Scales (PANSS)

    Baseline, 3, 6 and 9 months

  • Change in Subjective Experience of Psychosis Scale (SEPS)

    Baseline, 3, 6 and 9 months

  • Change in Depression Anxiety Stress Scale (DASS-21)

    Baseline, 3, 6 and 9 months

  • Change in Assessment of Quality of Life 8dimension (AQol8d)

    Baseline, 3, 6 and 9 months

  • Change in Resource Use Questionnaire

    Baseline, 3, 6 and 9 months

Other Outcomes (5)

  • Change in Self-Efficacy for Personal Recovery Scale

    Baseline, 3, 6 and 9 months

  • Change in General Self-Efficacy Scale

    Baseline, 3, 6 and 9 months

  • Change in Schizophrenia Hope Scale

    Baseline, 3, 6 and 9 months

  • +2 more other outcomes

Study Arms (2)

Health intervention

EXPERIMENTAL

\+ treatment as usual

Behavioral: Health intervention

Social intervention

ACTIVE COMPARATOR

\+ treatment as usual

Behavioral: Social intervention

Interventions

Participants will receive 8 50-minute sessions during a 3 month window with a mental health worker, in addition to their routine care. Sessions will be structured by the worker and participant using a tablet computer to view materials on mental health self-management and personal recovery on a dedicated website for the trial. These will include information, videos, audio and exercises. Online materials make particular use of videos featuring people with lived experience of psychosis discussing how they have dealt with issues in their recovery, and will allow users to post comments on videos and in a forum. Participants may access online materials both during intervention sessions and outside sessions using any Internet-enabled device.

Health intervention

Participants will receive 8 50-minute sessions during a 3 month window with a mental health worker in addition to routine care (treatment as usual). The social intervention will utilise a computer tablet (i.e., iPad) servicing online resources to extend a manualised befriending intervention, based upon social interaction, designed to control for therapist contact and computer use. Each session will involve interaction about non-health related topics of interest to the participants, which will be facilitated by use of viewing online material related to these interests on a tablet computer as a prompt to conversation.

Social intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of a functional psychotic disorder (schizophrenia-related disorder OR bipolar disorder or major depressive disorder with the presence of a severe episode with psychotic features within the past 2 years);
  • sufficient fluency in English to make use of the resources;
  • overall intellectual functioning within normal limits (WTAR estimated IQ\>70);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

EACH

Eastern Melbourne, Victoria, Australia

Location

Eastern Health

Eastern Melbourne, Victoria, Australia

Location

Mental Illness Fellowship of Victoria

Fairfield, Victoria, 3078, Australia

Location

St Vincent's Health mental health services

Fitzroy, Victoria, 3065, Australia

Location

Peninsula Health

Frankston, Victoria, Australia

Location

Austin Health

Heidelberg, Victoria, 3084, Australia

Location

Mind Australia

Heidelberg, Victoria, 3084, Australia

Location

Alfred Health mental health services

Melbourne, Victoria, 3004, Australia

Location

Neami National

Melbourne, Victoria, Australia

Location

North Western Mental Health

Melbourne, Victoria, Australia

Location

Related Publications (1)

  • Thomas N, Farhall J, Foley F, Rossell SL, Castle D, Ladd E, Meyer D, Mihalopoulos C, Leitan N, Nunan C, Frankish R, Smark T, Farnan S, McLeod B, Sterling L, Murray G, Fossey E, Brophy L, Kyrios M. Randomised controlled trial of a digitally assisted low intensity intervention to promote personal recovery in persisting psychosis: SMART-Therapy study protocol. BMC Psychiatry. 2016 Sep 7;16(1):312. doi: 10.1186/s12888-016-1024-1.

MeSH Terms

Conditions

SchizophreniaAffective Disorders, PsychoticPsychotic Disorders

Interventions

Play TherapySocial Work

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Neil Thomas

    Swinburne University of Technology/Alfred Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2015

First Posted

June 17, 2015

Study Start

January 1, 2015

Primary Completion

June 1, 2017

Study Completion

July 1, 2017

Last Updated

September 15, 2017

Record last verified: 2017-09

Locations